Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,311.50
-17.7 (-0.76%)
BSENSE

Apr 02

BSE+NSE Vol: 1.12 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
-0.76%
0.15%
1W
-0.44%
-2.55%
1M
-8.73%
-8.66%
YTD
-6.55%
-13.08%
1Y
-16.75%
-2.65%
3Y
74.49%
30.84%
5Y
61.4%
52.77%
10Y
21.3%
194.48%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.94%
0%
-6.94%
6 Months
-14.3%
0%
-14.3%
1 Year
-16.75%
0%
-16.75%
2 Years
17.3%
2.31%
19.61%
3 Years
74.49%
6.13%
80.62%
4 Years
39.39%
8.54%
47.93%
5 Years
61.4%
11.38%
72.78%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
1.25%
3
Quartile
quartile-3
Dec-Mar
-7.71%
4
Quartile
quartile-4
Sep-Dec
-7%
4
Quartile
quartile-4
1Y
-15.62%
2
Quartile
quartile-2
2025
9.85%
4
Quartile
quartile-4
2024
18.63%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
1.25%
2
Quartile
quartile-2
Dec-Mar
-7.71%
3
Quartile
quartile-3
Sep-Dec
-7%
3
Quartile
quartile-3
1Y
-15.62%
1
Quartile
quartile-1
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
1.25%
2
Quartile
quartile-2
Dec-Mar
-7.71%
4
Quartile
quartile-4
Sep-Dec
-7%
3
Quartile
quartile-3
1Y
-15.62%
2
Quartile
quartile-2
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available